Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is an open-label treatment program following basic prescribing information for patients with recurrent UPSC (Uterine Papillary Serous Carcinoma) to provide access to everolimus and limited treatment alternatives.
Epistemonikos ID: 59858fb7361cdfff5f06f3f6e20fea9d2aea60ec
First added on: May 21, 2024